fbpx
June 24, 2022

FDA Unveils 5-Year Plan for ALS, Other Neurodegenerative Diseases FDA Unveils 5-Year Plan for ALS, Other Neurodegenerative Diseases

The US Food and Drug Administration (FDA) has unveiled a 5-year strategy aimed at improving and extending the lives of people with rare neurodegenerative diseases. The […]
June 24, 2022

Noninvasive Brain Stim Promising for COVID-Related Smell Loss Noninvasive Brain Stim Promising for COVID-Related Smell Loss

Noninvasive brain stimulation may help restore a sense of smell in patients with chronic anosmia or hyposmia related to COVID-19, early research suggests. Results of a […]
June 23, 2022

Tofersen Linked to Slow but Positive ALS Outcomes Tofersen Linked to Slow but Positive ALS Outcomes

An open-label extension of Biogen’s phase 3 VALOR study shows statistically significant benefits for the company’s novel antisense oligonucleotide (ASO), tofersen, in patients with amyotrophic lateral […]
June 23, 2022

Promising New Tool for Better Migraine Management in Primary Care Promising New Tool for Better Migraine Management in Primary Care

A new tool can help streamline diagnosis and treatment of migraine in the primary care setting, new research suggests. Early results from a small pilot study […]
June 23, 2022

Top Medications Most Often Linked to Headache Top Medications Most Often Linked to Headache

DENVER, Colorado — Monoclonal antibodies, antivirals, immunomodulators, and pulmonary arterial vasodilators top the list of drugs that were most frequently implicated as causes of headaches in […]
June 23, 2022

Stroke Study Reveals a High Frequency of Mendelian Disorders Stroke Study Reveals a High Frequency of Mendelian Disorders

The study covered in this summary was published in medrxiv.org as a preprint and has not yet been peer reviewed. Key Takeaways Exome sequencing (ES) is […]
June 23, 2022

Sleep Tied to Objective and Subjective Cognition Sleep Tied to Objective and Subjective Cognition

Amy Costa Poor objective sleep efficiency may contribute to older adults overestimating their cognitive abilities, preliminary findings from a pilot study of objective and subjective cognitive […]
June 23, 2022

Recommended Drugs for Headache Rarely Prescribed in EDs Recommended Drugs for Headache Rarely Prescribed in EDs

DENVER – In line with recommendations, emergency departments dramatically reduced their use of opioids as treatments for headache over a recent 11-year period, a new study […]
June 23, 2022

More Positive Phase 3 Results ‘Raise the Bar’ for Migraine Drug More Positive Phase 3 Results ‘Raise the Bar’ for Migraine Drug

Atogepant, a small-molecule calcitonin gene-related peptide (CGRP) receptor antagonist approved last year for migraine, is superior to placebo not only in terms of a 50% or […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0